Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatment of Children Hospitalized With Bronchiolitis
Launched by JOHNS HOPKINS UNIVERSITY · Apr 10, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve the treatment of bronchiolitis, a common lung infection in young children, by using special reminders for doctors called best practice advisories (BPAs). The trial aims to find out if these reminders—either interruptive, which pause the doctor’s work to show the guideline, or non-interruptive, which simply provide the information without stopping their workflow—help doctors give better care according to established guidelines. Researchers will compare the outcomes of children with bronchiolitis treated by doctors who received these reminders against those who did not receive any.
To be eligible for this trial, children must be 24 months old or younger and be visiting the emergency room or hospitalized with bronchiolitis. Children who are in intensive care or have been hospitalized for more than 14 days will not be included. Participants will continue to receive the usual hospital care for bronchiolitis, and their doctors will have access to guidelines on how to treat the condition. This study aims to help ensure that children receive the best care possible when they are hospitalized for bronchiolitis.
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Children \<=24 months of age presenting to the emergency room and/or hospitalized (under observation or inpatient status) with bronchiolitis at one of three study sites.
- Patient Exclusion Criteria:
- • Current encounter is birth-encounter
- • Currently hospitalized in an ICU
- • Hospitalized with length of stay \>14 days
- Clinician Inclusion Criteria:
- • Physicians and advanced practice providers entering the patient's chart or orders entry activity for Emergency Department (ED) and inpatient encounters
- Clinician Exclusion Criteria:
- • Physicians and advanced practice providers who do not enter the patient's chart or orders entry activity
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Saint Petersburg, Florida, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Benjamin Bodnar, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported